BeiGene, Ltd. (BGNE): Price and Financial Metrics


BeiGene, Ltd. (BGNE)

Today's Latest Price: $170.36 USD

2.51 (1.50%)

Updated Jan 17 12:00am

Add BGNE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

BGNE Stock Summary

  • BGNE's went public 3.96 years ago, making it older than just 13.14% of listed US stocks we're tracking.
  • With a price/sales ratio of 23.29, BeiGene Ltd has a higher such ratio than 94.65% of stocks in our set.
  • Revenue growth over the past 12 months for BeiGene Ltd comes in at 172.62%, a number that bests 96.34% of the US stocks we're tracking.
  • Stocks that are quantitatively similar to BGNE, based on their financial statements, market capitalization, and price volatility, are XLRN, IDRA, AGIO, MCRB, and DRNA.
  • Visit BGNE's SEC page to see the company's official filings. To visit the company's web site, go to www.beigene.com.
BGNE Daily Price Range
BGNE 52-Week Price Range

BGNE Stock Price Chart More Charts


BGNE Price/Volume Stats

Current price $170.36 52-week high $210.35
Prev. close $167.85 52-week low $113.01
Day low $167.53 Volume 350,700
Day high $171.91 Avg. volume 328,358
50-day MA $181.84 Dividend yield N/A
200-day MA $143.44 Market Cap 10.40B

BeiGene, Ltd. (BGNE) Company Bio


BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops various oncology drugs in the People’s Republic of China. The company was founded in 2010 and is based in the Cayman Islands.





BGNE Latest News Stream


Event/Time News Detail
Loading, please wait...

BGNE Latest Social Stream


Loading social stream, please wait...

View Full BGNE Social Stream

BGNE Price Returns

1-mo 1.12%
3-mo 28.79%
6-mo 31.54%
1-year 18.90%
3-year 419.39%
5-year N/A
YTD 2.78%
2019 18.18%
2018 43.53%
2017 221.87%
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5283 seconds.